{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:31:19Z","timestamp":1781015479664,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.drugpo.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T01:15:18Z","timestamp":1346375718000},"page":"346-352","source":"Crossref","is-referenced-by-count":39,"title":["Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland"],"prefix":"10.1016","volume":"23","author":[{"given":"Elizabeth J.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah E.","family":"Palmateer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2012.07.006_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/apc.2009.0027","article-title":"At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City","volume":"23","author":"Arasteh","year":"2009","journal-title":"Aids Patient Care and STDS"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcv.2012.02.004","article-title":"Detection of hepatitis C virus RNA in dried blood spots","volume":"54","author":"Bennett","year":"2012","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.drugpo.2008.06.006","article-title":"Secondary exchange of sterile injecting equipment in a high distribution environment: A mixed method analysis in south east Sydney, Australia","volume":"20","author":"Bryant","year":"2009","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/kwh061","article-title":"Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: A cohort study","volume":"159","author":"Champion","year":"2004","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S095026880900212X","article-title":"Incidence of hepatitis C in drug injectors: The role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiology and Infection"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0030","series-title":"Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour","author":"European Centre for Disease Prevention and Control","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0035","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0040","series-title":"The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2007","author":"Health Protection Scotland and University of the West of Scotland","year":"2008"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0950268802006945","article-title":"Prevalence of hepatitis C among injectors in Scotland 1989\u20132000: Declining trends among young injectors halt in the late 1990s","volume":"128","author":"Hutchinson","year":"2002","journal-title":"Epidemiology and Infection"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0055","series-title":"Injecting Equipment Provision in Scotland Survey 2008\/09","author":"ISD Scotland","year":"2010"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0060","series-title":"Injecting Equipment Provision in Scotland Survey 2009\/10","author":"ISD Scotland","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.38286.841227.7C","article-title":"Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study","volume":"330","author":"Judd","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmv.10463","article-title":"Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots","volume":"71","author":"Judd","year":"2003","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0075","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/10826080600668746","article-title":"Threat or opportunity? Secondary exchange in a setting with widespread availability of needles","volume":"41","author":"Lenton","year":"2006","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0080","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/oxfordjournals.aje.a009227","article-title":"Invited commentary: Le mystere de Montreal","volume":"146","author":"Lurie","year":"1997","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0085","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0090","unstructured":"McDonald, S. A., Hutchinson, S. J., Cameron, S. O., Innes, H. A., McLeod, A., & Goldberg, D. J. (2012). Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. International Journal of Drug Policy, http:\/\/dx.doi.org\/10.1016\/j.drupo.2012.02.003."},{"key":"10.1016\/j.drugpo.2012.07.006_bib0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0950268806007035","article-title":"Hepatitis C virus infection among injecting drug users in Scotland: A review of prevalence and incidence data and the methods used to generate them","volume":"135","author":"Roy","year":"2007","journal-title":"Epidemiology and Infection"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drugalcdep.2010.04.004","article-title":"Determinants of alcohol consumption in HIV-uninfected injection drug users","volume":"111","author":"Sander","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0120","series-title":"Hepatitis C action plan for Scotland, phase II (May 2008\u2013March 2011)","author":"Scottish Government","year":"2008"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/jinf.2000.0647","article-title":"Prevalence of Hepatitis C virus infection among injecting drug users in Glasgow 1990\u20131996: Are current harm reduction strategies working?","volume":"40","author":"Taylor","year":"2000","journal-title":"Journal of Infection"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0135","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1099\/vir.0.033910-0","article-title":"The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals","volume":"92","author":"Thomson","year":"2011","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0145","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of Hepatitis C virus in injecting drug users: Pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0150","series-title":"The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2008\/2009","author":"University of the West of Scotland, Health Protection Scotland, & West of Scotland Specialist Virology Centre","year":"2010"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: A review","volume":"11","author":"Vallejo","year":"2004","journal-title":"American Journal of Therapeutics"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0160","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2012.07.006_bib0165","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1046\/j.1360-0443.1998.931116574.x","article-title":"Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities","volume":"93","author":"Vidal-Tr\u00e9can","year":"1998","journal-title":"Addiction"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395912001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395912001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T23:57:08Z","timestamp":1542758228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395912001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0955395912001144"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2012.07.006","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}